Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 18, 2022
Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on CognitionHanadi Ajam Oughli, Marie Anne Gebara, Adam Ciarleglio, et al.
Blood Advances|July 30, 2025
Single cell proteomics characterization of bone marrow hematopoiesis with distinct Ras pathway lesionsLaila Karra, Anna-Marie Finger, Lauren A Shechtman, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 29, 2024
Poor Sleep is Common in Treatment-Resistant Late-life Depression and Associated With Poorer Antidepressant Response: Findings From the OPTIMUM Clinical TrialMichael S B Mak, Marie Anne Gebara, Eric J Lenze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2012
A phospholipase C-γ1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant miceRobert L Kortum, Alexandre K Rouquette-Jazdanian, Michihiko Miyaji, et al.
Science Signaling|March 28, 2013
Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesisCatherine Hartzell, Olga Ksionda, Ed Lemmens, et al.
JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.
The New England Journal of Medicine|March 3, 2023
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric DepressionEric J Lenze, Benoit H Mulsant, Steven P Roose, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2022
Immediate myeloid depot for SARS-CoV-2 in the human lungMélia Magnen, Ran You, Arjun A Rao, et al.
Research Square|May 25, 2022
Immediate myeloid depot for SARS-CoV-2 in the human lungMélia Magnen, Ran You, Arjun A Rao, et al.
Nature|September 4, 2009
Response and resistance to MEK inhibition in leukaemias initiated by hyperactive RasJennifer O Lauchle, Doris Kim, Doan T Le, et al.
Pageof 27